Chinese VC Firms Return to Fundraising as AI, Robotics Draw LPs

Chinese venture firms are back in the market with new funds, and the shape of this recovery is not the shape of the last cycle. The Financial Times reports that after years of fundraising decline, GPs are opening vehicles again, with LPs redirecting capital toward domestic AI and robotics.

The specifics matter on both sides of the equation. On the LP side, newly registered VC funds in China reached 154 billion yuan in the first five months of 2026, already exceeding the entire previous year according to China's fund industry association. On the deal side, DeepSeek pulled in $7.4 billion in its first external round at a valuation reportedly above $50 billion, and per Fortune is now sounding out further capital at up to $71 billion, while Moonshot AI is finalising a round that values it above $30 billion ahead of a planned Hong Kong listing. Chinese robotics companies alone raised roughly $5.6 billion through mid-May 2026 across 176 deals, already eclipsing the $4.3 billion raised in all of 2025, Crunchbase News reports.

Why this matters to a non-China allocator is that it changes who you can actually back. The last cycle's Chinese VC pitch was generalist consumer internet plus a bit of enterprise software. This one is much narrower: embodied AI, humanoid robotics, semiconductors, and the state-adjacent capital that funds them. The lead investor in DeepSeek's round was reportedly the China Integrated Circuit Industry Investment Fund, the same government vehicle behind the country's biggest chipmakers, and Beijing has told firms including Moonshot, StepFun and ByteDance not to accept US capital in new rounds without explicit government clearance.

The honest caveat is that this reads less like a broad thaw and more like a targeted redirection of domestic capital into strategic sectors. Zero2IPO's numbers show foreign-currency deal count rebounding off a low base, but the split between genuinely returning international LPs and recycled domestic pools is not fully visible in what has been reported, and the exit path for these funds still leans on Hong Kong rather than New York. Take the specifics as reported, not settled.

The forward look is straightforward. Managers with a credible AI or robotics thesis in China are having their first real fundraising window since the drought began. If DeepSeek and Moonshot's Hong Kong listings clear at anything close to their marked valuations, expect the next wave of new funds to be materially larger than this one.